Neurogene stock surges 30% on FDA breakthrough therapy status

Finance
1



[
Neurogene stock surges 30% on FDA breakthrough therapy status
[og_img]
https://www.investing.com/news/stock-market-news/neurogene-stock-surges-30-on-fda-breakthrough-therapy-status-93CH-4529875


Investing.com

Montather Rassoul
Montather Rassoulhttps://thefifthskill.com/

Latest articles

spot_imgspot_img
Previous article
Rolex has just opened a trade school for watchmakers in Texas. Already competition is as fierce as Harvard’s, and students could walk out with $95,000 jobs
Next article
MacKenzie Scott gave away $7.2 billion in just one year. That’s more than Jeff Bezos and most other billionaires have donated in their lifetimes

Related articles

spot_imgspot_img